Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival
Keywords: حلال; Dose; Schedule; Solvent; Taxane; Treatment-naive